HighTower Advisors’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$30.8M Sell
393,328
-929,333
-70% -$75M 0.03% 510
2026
Q1
$115M Sell
1,322,661
-122,260
-8% -$11.7M 0.12% 172
2025
Q4
$139M Sell
1,444,921
-15,683
-1% -$1.52M 0.15% 140
2025
Q3
$139M Sell
1,460,604
-28,958
-2% -$2.66M 0.16% 139
2025
Q2
$130M Sell
1,489,562
-3,592
-0.2% -$305K 0.16% 137
2025
Q1
$134M Buy
1,493,154
+53,907
+4% +$4.82M 0.18% 126
2024
Q4
$115M Sell
1,439,247
-14,383
-1% -$1.25M 0.16% 144
2024
Q3
$131M Buy
1,453,630
+123,475
+9% +$10.4M 0.19% 123
2024
Q2
$105M Sell
1,330,155
-45,044
-3% -$3.69M 0.16% 142
2024
Q1
$120M Sell
1,375,199
-37,377
-3% -$3.19M 0.19% 116
2023
Q4
$116M Sell
1,412,576
-40,578
-3% -$3.09M 0.2% 117
2023
Q3
$114M Buy
1,453,154
+43,848
+3% +$3.67M 0.21% 104
2023
Q2
$124M Buy
1,409,306
+109,999
+8% +$9.47M 0.24% 83
2023
Q1
$105M Buy
1,299,307
+78,064
+6% +$6.36M 0.23% 91
2022
Q4
$94.9M Sell
1,221,243
-67,136
-5% -$5.44M 0.22% 100
2022
Q3
$104M Buy
1,288,379
+54,885
+4% +$4.93M 0.28% 72
2022
Q2
$111M Buy
1,233,494
+38,661
+3% +$3.92M 0.29% 75
2022
Q1
$133M Buy
1,194,833
+79,428
+7% +$8.39M 0.3% 72
2021
Q4
$115M Buy
1,115,405
+282,937
+34% +$32.8M 0.25% 92
2021
Q3
$105M Buy
832,468
+33,845
+4% +$4.38M 0.28% 78
2021
Q2
$98.9M Buy
798,623
+65,771
+9% +$8.26M 0.29% 81
2021
Q1
$86.6M Buy
732,852
+71,388
+11% +$8.37M 0.27% 83
2020
Q4
$77.6M Buy
661,464
+375,005
+131% +$41.3M 0.32% 65
2020
Q3
$29.7M Sell
286,459
-46,663
-14% -$4.69M 0.14% 149
2020
Q2
$30.6M Buy
333,122
+60,379
+22% +$5.79M 0.17% 137
2020
Q1
$24.6M Buy
272,743
+34,658
+15% +$3.69M 0.16% 143
2019
Q4
$27M Buy
238,085
+12,652
+6% +$1.39M 0.16% 146
2019
Q3
$24.5M Sell
225,433
-32,843
-13% -$3.43M 0.13% 161
2019
Q2
$25.2M Buy
258,276
+13,155
+5% +$1.2M 0.15% 143
2019
Q1
$22.3M Sell
245,121
-24,110
-9% -$2.16M 0.15% 144
2018
Q4
$24.5M Sell
269,231
-15,260
-5% -$1.43M 0.19% 116
2018
Q3
$28M Buy
284,491
+35,188
+14% +$3.25M 0.2% 97
2018
Q2
$21.3M Buy
249,303
+52,701
+27% +$4.4M 0.17% 127
2018
Q1
$15.7M Buy
196,602
+2,740
+1% +$226K 0.13% 173
2017
Q4
$15.6M Buy
193,862
+3,774
+2% +$302K 0.13% 170
2017
Q3
$14.8M Sell
190,088
-79,837
-30% -$6.63M 0.13% 169
2017
Q2
$23.9M Buy
269,925
+19,829
+8% +$1.67M 0.21% 99
2017
Q1
$20.1M Buy
250,096
+32,253
+15% +$2.52M 0.19% 111
2016
Q4
$15.5M Buy
217,843
+40,663
+23% +$3.19M 0.17% 120
2016
Q3
$15.3M Buy
177,180
+16,514
+10% +$1.44M 0.18% 118
2016
Q2
$13.9M Sell
160,666
-6,443
-4% -$521K 0.18% 121
2016
Q1
$12.6M Sell
167,109
-8,306
-5% -$626K 0.04% 159
2015
Q4
$13.5M Buy
175,415
+31,379
+22% +$2.36M 0.16% 137
2015
Q3
$9.63M Buy
144,036
+12,025
+9% +$886K 0.13% 179
2015
Q2
$9.78M Sell
132,011
-22,221
-14% -$1.7M 0.16% 132
2015
Q1
$12M Sell
154,232
-9,288
-6% -$704K 0.18% 127
2014
Q4
$11.8M Sell
163,520
-38,053
-19% -$2.64M 0.18% 125
2014
Q3
$12.5M Buy
201,573
+10,153
+5% +$646K 0.21% 108
2014
Q2
$12.2M Buy
191,420
+3,935
+2% +$239K 0.21% 102
2014
Q1
$11.5M Buy
187,485
+6,576
+4% +$383K 0.23% 95
2013
Q4
$10.4M Sell
180,909
-14,432
-7% -$818K 0.21% 109
2013
Q3
$10.4M Sell
195,341
-377
-0.2% -$20.3K 0.26% 83
2013
Q2
$10.1M Buy
+195,718
New +$9.67M 0.27% 79

Other funds holding MDT

HighTower Advisors's MDT Position: Q2 2026 in Review

HighTower Advisors reduced its Medtronic (MDT) stake by 70% in Q2 2026, selling an estimated $75M and leaving 393,328 shares worth $30.8M. The position accounts for 0.03% of the portfolio, ranked #510.

HighTower Advisors first reported a position in MDT in Q2 2013 and has held it in 53 quarters since. The position peaked at $139M in Q3 2025. 2,123 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

  • HighTower Advisors held 393,328 shares of Medtronic worth $30.8M as of Q2 2026.
  • HighTower Advisors sold 929,333 Medtronic shares in Q2 2026, an estimated $75M.
  • Medtronic made up 0.03% of HighTower Advisors's portfolio in Q2 2026, its #510 holding.
  • HighTower Advisors first reported a position in Medtronic in Q2 2013 and has held it in 53 quarters since.
  • HighTower Advisors's Medtronic position peaked at $139M in Q3 2025.
  • 2,123 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on HighTower Advisors's 13F filing for Q2 2026, filed 5 Aug 2026.